XOOMAR
Get a free API key

Novartis (NVS)

Novartis on one page: short interest, daily short volume, fails to deliver, planned sales and 13F holders. Listed on NYSE, classified by the SEC as pharmaceutical preparations.

Download CSV

5.6M

Short interest

settlement 2026-09-30

2.9

Days to cover

+1.5 days vs prior

12.3%

Short share of volume

2026-10-09

41,500

Fails to deliver

settlement 2026-09-10

As of 2026-10-09.

Short interest

FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in NVS is 5,624,031 shares, down 1,127 shares over the last month. Over the last 48 readings it ranged from 3,225,456 shares (31 March 2025) to 7,533,454 shares (13 March 2026). At the reported average volume of 1.9M shares a day that is 2.9 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/nvs" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-09-305,624,031+8.2%1,921,2892.93
2026-09-155,195,725-7.6%3,525,8321.47
2026-08-315,625,158+12.7%1,333,4064.22
2026-08-144,993,689-4.7%1,455,7293.43
2026-07-315,240,722-8.3%1,951,5242.69
2026-07-155,713,789+6.7%1,590,0643.59
2026-06-305,355,498+2.1%2,749,7671.95
2026-06-155,246,790+15.5%2,051,0912.56
2026-05-294,543,531+1.5%1,237,3913.67
2026-05-154,475,369-0.3%1,270,4833.52
2026-04-304,488,888-22.4%1,524,2172.95
2026-04-155,785,672-7.5%1,468,4433.94
2026-03-316,255,669-17.0%1,834,4583.41
2026-03-137,533,454+10.0%3,080,9122.45
2026-02-276,848,820-8.5%2,802,6592.44
2026-02-137,488,605+46.4%3,031,5432.47
2026-01-305,116,628-9.4%1,830,9772.79
2026-01-155,650,772-5.7%1,673,0013.38
2025-12-315,989,213+10.4%1,266,3314.73
2025-12-155,422,912+9.0%1,766,9383.07
2025-11-284,976,663-8.3%1,848,5742.69
2025-11-145,426,777-5.6%1,450,0773.74
2025-10-315,749,914+32.2%1,861,5933.09
2025-10-154,348,833-0.1%1,900,3962.29

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 9 October 2026, the short share of NVS volume is 12.3%, down 9.9 points over the last five sessions. Over the last 30 readings it ranged from 12.3% (9 October 2026) to 61.7% (31 August 2026). The latest reading sits at the bottom of that range. The latest reading is 24.0 points below the 30-session average of 36.2%, on 661K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-10-0981K661K12.3%1,220
2026-10-08149K548K27.1%1,220
2026-10-07212K683K31.0%3,443
2026-10-06105K686K15.3%600
2026-10-0594K508K18.5%1,008
2026-10-02207K935K22.1%3,594
2026-10-01298K790K37.7%1,159
2026-09-30479K1.1M42.7%4,374
2026-09-29226K537K42.0%1,898
2026-09-28273K647K42.2%156
2026-09-25172K420K40.9%1,699
2026-09-24333K844K39.4%7
2026-09-23366K835K43.8%622
2026-09-22176K612K28.7%4,348
2026-09-21176K671K26.3%3,031
2026-09-18190K634K30.0%250
2026-09-17200K585K34.2%963
2026-09-16277K712K38.8%6,067
2026-09-15179K757K23.7%1,918
2026-09-14248K1.1M22.9%613
2026-09-11238K692K34.4%396
2026-09-10277K828K33.5%2,821
2026-09-09573K1.4M40.0%57,217
2026-09-082.4M4.5M53.5%106,743
2026-09-04241K426K56.6%155
2026-09-03356K717K49.6%3,494
2026-09-02825K2.5M33.0%9,567
2026-09-01731K1.7M44.2%5,020
2026-08-31319K517K61.7%2,100
2026-08-28249K411K60.6%203

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 10 September 2026, the fails-to-deliver balance in NVS is 41,500 shares, up 39,751 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (17 July 2026) to 72,516 shares (21 August 2026).

SettlementShares failedPriceValue
2026-09-1041,500$137.48$5.7M
2026-09-041,749$163.09$285K
2026-09-0260$161.25$10K
2026-08-2737$157.54$6K
2026-08-2172,516$156.24$11.3M
2026-08-18170$151.97$26K
2026-08-1725$150.88$4K
2026-08-1414,889$151.72$2.3M
2026-08-127,145$154.61$1.1M
2026-08-1011,391$156.33$1.8M
2026-08-0733,184$154.21$5.1M
2026-08-05140$153.27$21K
2026-08-0424,310$153.67$3.7M
2026-08-034,836$156.15$755K
2026-07-30314$158.83$50K
2026-07-2951$159.85$8K
2026-07-283,042$156.11$475K
2026-07-2494$156.14$15K
2026-07-20400$153.76$62K
2026-07-171$152.73$153
2026-07-07363$155.49$56K
2026-07-015,168$156.72$810K
2026-06-2963,975$155.41$9.9M
2026-06-25132$153.12$20K
2026-06-24129$153.38$20K
2026-06-233,381$148.93$504K
2026-06-182,531$150.88$382K
2026-06-1744$150.93$7K
2026-06-15244$153.07$37K
2026-06-1214,646$153.92$2.3M

Planned sales (Form 144)

Newest first. JSON

3 Form 144 notices on file for NVS worth $7.1M at the prices reported; 0 in the last 90 days worth $0. Latest: Bulto Carulla Victor filed on 2026-04-30 to sell 6,800 shares ($1.0M) from 2026-04-30.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-04-30Bulto Carulla VictorOfficer7K$1.0M0.000%2026-04-30Fidelity Brokerage Services LLC
2026-02-12Marshall FionaOfficer31K$5.0M0.002%2026-02-12Fidelity Brokerage Services LLC
2026-02-09Bulto Carulla VictorOfficer8K$1.2M0.000%2026-02-09Fidelity Brokerage Services LLC

13F holders

Tracked managers holding NVS at their latest 13F. JSON

7 of the 30 tracked managers held NVS at their latest 13F, $2.79B in total at quarter-end prices. Fisher Asset Management is the largest at $2.43B (0.7% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 3 cut.

FundQuarterSharesValueOf portfolioChange in shares
Fisher Asset Management2026-06-3015.5M$2.43B0.72%+1.6M
Renaissance Technologies2026-06-30788K$123.5M0.17%-324K
Millennium Management2026-06-30758K$118.8M0.04%new
Citadel Advisors2026-06-30321K$50.3M0.01%new
AQR Capital Management2026-06-30281K$44.1M0.02%+47K
Point72 Asset Management2026-06-30106K$16.6M0.02%-178K
Two Sigma Investments2026-06-3014K$2.2M0.00%-14K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Novartis in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Novartis (NVS), SEC CIK 1114448, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-10.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-04-30.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Company record
EDGAR filing index for CIK 1114448Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as pharmaceutical preparations

Datasets

Frequently Asked Questions

How much of NVS is sold short?
5,624,031 shares were held short at the 2026-09-30 settlement, 2.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NVS's daily short volume?
On 2026-10-09, 81,106 of the 660,922 NVS shares reported to FINRA were sold short, 12.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NVS have fails to deliver?
The SEC's latest file shows 41,500 NVS shares failed to deliver at settlement 2026-09-10. Fails are reported per settlement date and published twice a month with a lag.
Are NVS insiders buying or selling?
No Form 4 filings for NVS are on record.
Have NVS insiders filed to sell?
3 Form 144 notices on file for NVS worth $7.1M at the prices reported; 0 in the last 90 days worth $0. Latest: Bulto Carulla Victor filed on 2026-04-30 to sell 6,800 shares ($1.0M) from 2026-04-30.
Which tracked 13F managers own NVS?
7 of the 30 tracked 13F managers held NVS shares at their latest filing, $2.79B in all. The largest: Ken Fisher's Fisher Asset Management (15.5M shares, $2.43B), Renaissance Technologies (788K shares, $123.5M), Izzy Englander's Millennium Management (758K shares, $118.8M), Ken Griffin's Citadel Advisors (321K shares, $50.3M), Cliff Asness's AQR Capital Management (281K shares, $44.1M), Steve Cohen's Point72 Asset Management (106K shares, $16.6M). The table above lists all 7.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.